BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31522881)

  • 1. RBE-weighted dose in carbon ion therapy for ACC patients: Impact of the RBE model translation on treatment outcomes.
    Molinelli S; Bonora M; Magro G; Casale S; Dale JE; Fossati P; Hasegawa A; Mirandola A; Ronchi S; Russo S; Preda L; Valvo F; Orecchia R; Ciocca M; Vischioni B
    Radiother Oncol; 2019 Dec; 141():227-233. PubMed ID: 31522881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose prescription in carbon ion radiotherapy: How to compare two different RBE-weighted dose calculation systems.
    Molinelli S; Magro G; Mairani A; Matsufuji N; Kanematsu N; Inaniwa T; Mirandola A; Russo S; Mastella E; Hasegawa A; Tsuji H; Yamada S; Vischioni B; Vitolo V; Ferrari A; Ciocca M; Kamada T; Tsujii H; Orecchia R; Fossati P
    Radiother Oncol; 2016 Aug; 120(2):307-12. PubMed ID: 27394694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid effective dose calculation for raster-scanning
    Kopp B; Mein S; Tessonnier T; Besuglow J; Harrabi S; Heim E; Abdollahi A; Haberer T; Debus J; Mairani A
    Phys Med; 2021 Jan; 81():273-284. PubMed ID: 33353795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How LEM-based RBE and dose-averaged LET affected clinical outcomes of sacral chordoma patients treated with carbon ion radiotherapy.
    Molinelli S; Magro G; Mairani A; Allajbej A; Mirandola A; Chalaszczyk A; Imparato S; Ciocca M; Fiore MR; Orlandi E
    Radiother Oncol; 2021 Oct; 163():209-214. PubMed ID: 34506829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RBE-weighted dose conversions for patients with recurrent nasopharyngeal carcinoma receiving carbon-ion radiotherapy from the local effect model to the microdosimetric kinetic model.
    Zhang L; Wang W; Hu J; Lu J; Kong L
    Radiat Oncol; 2020 Dec; 15(1):277. PubMed ID: 33302998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RBE-weighted doses in target volumes of chordoma and chondrosarcoma patients treated with carbon ion radiotherapy: Comparison of local effect models I and IV.
    Gillmann C; Jäkel O; Karger CP
    Radiother Oncol; 2019 Dec; 141():234-238. PubMed ID: 31522880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organs at risk dose constraints in carbon ion radiotherapy at MedAustron: Translations between LEM and MKM RBE models and preliminary clinical results.
    Grosshagauer S; Fossati P; Schafasand M; Carlino A; Poljanc K; Radakovits T; Stock M; Hug E; Georg P; Pelak M; Góra J
    Radiother Oncol; 2022 Oct; 175():73-78. PubMed ID: 35952977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal lobe reactions after carbon ion radiation therapy: comparison of relative biological effectiveness-weighted tolerance doses predicted by local effect models I and IV.
    Gillmann C; Jäkel O; Schlampp I; Karger CP
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1136-41. PubMed ID: 24661667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RBE-weighted dose conversions for carbon ionradiotherapy between microdosimetric kinetic model and local effect model for the targets and organs at risk in prostate carcinoma.
    Wang W; Huang Z; Sheng Y; Zhao J; Shahnazi K; Zhang Q; Jiang G
    Radiother Oncol; 2020 Mar; 144():30-36. PubMed ID: 31710941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sacral-Nerve-Sparing Planning Strategy in Pelvic Sarcomas/Chordomas Treated with Carbon-Ion Radiotherapy.
    Nachankar A; Schafasand M; Hug E; Martino G; Góra J; Carlino A; Stock M; Fossati P
    Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38610962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose averaged linear energy transfer optimization for large sacral chordomas in carbon ion therapy.
    Schafasand M; Resch AF; Nachankar A; Góra J; Martino G; Traneus E; Glimelius L; Georg D; Fossati P; Carlino A; Stock M
    Med Phys; 2024 Jun; 51(6):3950-3960. PubMed ID: 38696546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion and validation of rectal constraints for prostate carcinoma receiving hypofractionated carbon-ion radiotherapy with a local effect model.
    Wang W; Li P; Sheng Y; Huang Z; Zhao J; Hong Z; Shahnazi K; Jiang GL; Zhang Q
    Radiat Oncol; 2021 Apr; 16(1):72. PubMed ID: 33849589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing biological effectiveness guided plan optimization strategies for cranial proton therapy: potential and challenges.
    Hahn C; Heuchel L; Ödén J; Traneus E; Wulff J; Plaude S; Timmermann B; Bäumer C; Lühr A
    Radiat Oncol; 2022 Oct; 17(1):169. PubMed ID: 36273132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose prescription in carbon ion radiotherapy: a planning study to compare NIRS and LEM approaches with a clinically-oriented strategy.
    Fossati P; Molinelli S; Matsufuji N; Ciocca M; Mirandola A; Mairani A; Mizoe J; Hasegawa A; Imai R; Kamada T; Orecchia R; Tsujii H
    Phys Med Biol; 2012 Nov; 57(22):7543-54. PubMed ID: 23104051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A modified microdosimetric kinetic model for relative biological effectiveness calculation.
    Chen Y; Li J; Li C; Qiu R; Wu Z
    Phys Med Biol; 2017 Dec; 63(1):015008. PubMed ID: 29240558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatial correlation of linear energy transfer and relative biological effectiveness with suspected treatment-related toxicities following proton therapy for intracranial tumors.
    Ödén J; Toma-Dasu I; Witt Nyström P; Traneus E; Dasu A
    Med Phys; 2020 Feb; 47(2):342-351. PubMed ID: 31705671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-response curves for MRI-detected radiation-induced temporal lobe reactions in patients after proton and carbon ion therapy: Does the same RBE-weighted dose lead to the same biological effect?
    Gillmann C; Lomax AJ; Weber DC; Jäkel O; Karger CP
    Radiother Oncol; 2018 Jul; 128(1):109-114. PubMed ID: 29459152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brainstem NTCP and Dose Constraints for Carbon Ion RT-Application and Translation From Japanese to European RBE-Weighted Dose.
    Dale JE; Molinelli S; Vischioni B; Vitolo V; Bonora M; Magro G; Mairani A; Hasegawa A; Ohno T; Dahl O; Valvo F; Fossati P
    Front Oncol; 2020; 10():531344. PubMed ID: 33330020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calibration and evaluation of the relative biological effectiveness for carbon-ion radiotherapy in a new relative to a clinically applied treatment planning system.
    Wang W; Huang Z; Sun W; Wang X; Zhao J; Shen H
    Radiat Oncol; 2022 Dec; 17(1):219. PubMed ID: 36587224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of RBE-Weighted Dose Models for Carbon Ion Therapy Toward Modernization of Clinical Practice at HIT: In Vitro, in Vivo, and in Patients.
    Mein S; Klein C; Kopp B; Magro G; Harrabi S; Karger CP; Haberer T; Debus J; Abdollahi A; Dokic I; Mairani A
    Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):779-791. PubMed ID: 32504659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.